Axq Capital »

Halozyme Therapeutics shares owned by Axq Capital

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Axq Capital from 13F filings

Historical chart of Axq Capital investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Axq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Axq Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.4M 31k 78.27
2026-03-31 $941k 15k 64.63
2025-06-30 $385k 7.4k 52.02
2022-12-31 $485k 8.5k 56.90